(TU) Telus - Ratings and Ratios
Mobile, Internet, TV, Security, Health
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 9.17% |
| Yield on Cost 5y | 7.92% |
| Yield CAGR 5y | 0.60% |
| Payout Consistency | 92.0% |
| Payout Ratio | 1.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 18.4% |
| Value at Risk 5%th | 29.1% |
| Relative Tail Risk | -3.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -2.72 |
| CAGR/Max DD | -0.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.412 |
| Beta | -0.007 |
| Beta Downside | -0.192 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.95% |
| Mean DD | 16.04% |
| Median DD | 17.02% |
Description: TU Telus December 17, 2025
Telus Corp (NYSE:TU) operates two primary divisions: Technology Solutions, which delivers a broad portfolio of telecom infrastructure, mobile and fixed voice/data services, cloud, data analytics, and health-tech offerings; and Digitally-Led Customer Experiences, focused on AI-driven digital transformation, content management, and customer-engagement platforms.
Key operating metrics (2023) include ≈ $15.9 billion in total revenue, a 13.2% EBITDA margin, and roughly 13 million wireless subscribers, with a 5-year CAGR of ~2.5% in post-paid lines. Growth is driven by continued 5G rollout, rising demand for health-technology services (e.g., Telus Health’s virtual care platform now serves over 1 million users), and a regulated Canadian telecom market that limits price competition but ensures stable cash flows. Capital expenditures remain high, with FY2024 capex guidance of $2.2 billion, reflecting network expansion and cloud infrastructure investment.
For a deeper quantitative view, you may find ValueRay’s detailed financial models useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.18b TTM) > 0 and > 6% of Revenue (6% = 1.23b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 2.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -8.30% (prev -13.86%; Δ 5.56pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 4.39b > Net Income 1.18b (YES >=105%, WARN >=100%) |
| Net Debt (20.16b) to EBITDA (6.75b) ratio: 2.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.54b) change vs 12m ago 3.84% (target <= -2.0% for YES) |
| Gross Margin 61.94% (prev 61.99%; Δ -0.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.20% (prev 35.03%; Δ 6.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.83 (EBITDA TTM 6.75b / Interest Expense TTM 1.50b) >= 6 (WARN >= 3) |
Altman Z'' 0.50
| (A) -0.04 = (Total Current Assets 5.30b - Total Current Liabilities 7.00b) / Total Assets 42.26b |
| (B) 0.01 = Retained Earnings (Balance) 359.0m / Total Assets 42.26b |
| (C) 0.06 = EBIT TTM 2.73b / Avg Total Assets 49.62b |
| (D) 0.34 = Book Value of Equity 10.22b / Total Liabilities 29.68b |
| Total Rating: 0.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.24
| 1. Piotroski 3.50pt |
| 2. FCF Yield 4.66% |
| 3. FCF Margin 10.66% |
| 4. Debt/Equity 1.88 |
| 5. Debt/Ebitda 2.99 |
| 6. ROIC - WACC (= 0.38)% |
| 7. RoE 8.15% |
| 8. Rev. Trend 77.12% |
| 9. EPS Trend -47.50% |
What is the price of TU shares?
Over the past week, the price has changed by +2.30%, over one month by +1.66%, over three months by -15.85% and over the past year by +2.20%.
Is TU a buy, sell or hold?
- Strong Buy: 3
- Buy: 5
- Hold: 9
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the TU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.8 | 30.5% |
| Analysts Target Price | 16.8 | 30.5% |
| ValueRay Target Price | 13.6 | 5.7% |
TU Fundamental Data Overview December 27, 2025
P/E Trailing = 22.4737
P/E Forward = 16.0772
P/S = 0.9717
P/B = 1.7131
P/EG = 1.9342
Beta = 0.779
Revenue TTM = 20.45b CAD
EBIT TTM = 2.73b CAD
EBITDA TTM = 6.75b CAD
Long Term Debt = 25.79b CAD (from longTermDebt, last quarter)
Short Term Debt = 2.96b CAD (from shortTermDebt, last quarter)
Debt = 21.48b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.16b CAD (from netDebt column, last quarter)
Enterprise Value = 46.80b CAD (27.16b + Debt 21.48b - CCE 1.83b)
Interest Coverage Ratio = 1.83 (Ebit TTM 2.73b / Interest Expense TTM 1.50b)
FCF Yield = 4.66% (FCF TTM 2.18b / Enterprise Value 46.80b)
FCF Margin = 10.66% (FCF TTM 2.18b / Revenue TTM 20.45b)
Net Margin = 5.77% (Net Income TTM 1.18b / Revenue TTM 20.45b)
Gross Margin = 61.94% ((Revenue TTM 20.45b - Cost of Revenue TTM 7.78b) / Revenue TTM)
Gross Margin QoQ = 61.67% (prev 63.07%)
Tobins Q-Ratio = 1.11 (Enterprise Value 46.80b / Total Assets 42.26b)
Interest Expense / Debt = 1.86% (Interest Expense 400.0m / Debt 21.48b)
Taxrate = 26.70% (157.0m / 588.0m)
NOPAT = 2.00b (EBIT 2.73b * (1 - 26.70%))
Current Ratio = 0.76 (Total Current Assets 5.30b / Total Current Liabilities 7.00b)
Debt / Equity = 1.88 (Debt 21.48b / totalStockholderEquity, last quarter 11.40b)
Debt / EBITDA = 2.99 (Net Debt 20.16b / EBITDA 6.75b)
Debt / FCF = 9.25 (Net Debt 20.16b / FCF TTM 2.18b)
Total Stockholder Equity = 14.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.79% (Net Income 1.18b / Total Assets 42.26b)
RoE = 8.15% (Net Income TTM 1.18b / Total Stockholder Equity 14.46b)
RoCE = 6.79% (EBIT 2.73b / Capital Employed (Equity 14.46b + L.T.Debt 25.79b))
RoIC = 4.32% (NOPAT 2.00b / Invested Capital 46.29b)
WACC = 3.95% (E(27.16b)/V(48.63b) * Re(5.99%) + D(21.48b)/V(48.63b) * Rd(1.86%) * (1-Tc(0.27)))
Discount Rate = 5.99% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 2.52%
[DCF Debug] Terminal Value 80.72% ; FCFE base≈1.96b ; Y1≈2.29b ; Y5≈3.47b
Fair Price DCF = 38.40 (DCF Value 59.56b / Shares Outstanding 1.55b; 5y FCF grow 18.29% → 3.0% )
EPS Correlation: -47.50 | EPS CAGR: -1.51% | SUE: -1.33 | # QB: 0
Revenue Correlation: 77.12 | Revenue CAGR: 3.46% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.18 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=0.77 | Chg30d=-0.006 | Revisions Net=-3 | Growth EPS=+9.4% | Growth Revenue=+2.5%
Additional Sources for TU Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle